Analysts at StockNews.com began coverage on shares of bluebird bio (NASDAQ:BLUE – Get Free Report) in a research note issued on Tuesday. The brokerage set a “sell” rating on the biotechnology ...
(NASDAQ:BLUE – Get Free Report) had its target price dropped by analysts at Wells Fargo & Company from $40.00 to $5.00 in a ...
Francis Creek Sportsman’s Club will host its 23rd annual “Show Off Your Buck Contest” March 1 at its clubhouse on the corner ...
Latest chapter in partnership between leading telco and low Earth orbit satellite provider sees firms unveil new organisation ...
In the 1920s and 1930s national heroes were the breed who sought glory by pushing the boundaries on land, water, and in the ...
Intellia Therapeutics’ stock faces risks from market uncertainty and funding needs. Read why NTLA stock is downgraded to HOLD ...
7hon MSN
The changes at Spark follow Roche's decision last year to halt development of a gene therapy for hemophilia A that was the ...
AST SpaceMobile (NASDAQ: ASTS) stock opened dramatically higher on Monday morning, up 7.3% over the weekend after an ...
AST SpaceMobile (AST) and Vodafone used the Mobile World Congress in Barcelona, as well as AST’s financial results, to ...
2025's final numbers. Friends of Branch River holding bluebird house painting for kids Friends of Branch River Watershed will again hold a bluebird house painting for youngsters. It will be at ...
The move will see Martin Williams take charge of brands including Coq d’Argent, Bluebird, German Gymnasium, Quaglino’s and ...
As bluebird bio struggles to get its gene therapies ... That means it needs to raise additional funding, and the biotech is looking at a number of options including the possible sale of priority ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback